Literature DB >> 12516000

Prevalence of mycosis fungoides and its association with EBV and HTLV-1 in Pakistanian patients.

Samina Noorali1, Nausheen Yaqoob, Muhammad Israr Nasir, Tariq Moatter, Shahid Pervez.   

Abstract

Mycosis fungoides (MF) is an indolent T cell lymphoma that is distinguished from other lymphomas by its initial appearance on the skin. The histologic diagnosis of MF may be difficult because there is significant overlap in the histologic features of neoplastic T-cell infiltrates and inflammatory dermatoses. This T-cell neoplasm commonly occurs in a mixed, reactive background and can show only a subtle degree of cytologic atypia, rendering histologic diagnosis difficult. In this study MF constituted 0.86% of all non-Hodgkin s lymphoma (NHL) both T and B, as compared to the Western studies which have reported 0.5% prevalence for MF of all NHL. Polymerase chain reaction (PCR) technique was used to assess T-cell clonality in paraffin-embedded skin biopsies clinically and pathologically suspicious for early MF. Out of the 14 cases diagnosed as MF, amplifiable DNA was isolated from 6 cases, which were further studied for T-cell receptor (TcR) beta, gamma, and delta chain gene rearrangements. Clonal product was seen in 4 out of 6 cases for beta, gamma, and delta TcR chain genes. Association for Epstein Barr virus (EBV) was observed in 3 out of 6 cases (50%) of MF. Although these 3 cases were positive for EBV by PCR, but were negative by in-situ hybridization (ISH). No heterogeneity was noted in these 3 cases of MF for BamHI E, K, N, and Z regions of EBV. All six cases were negative for HTLV-1 (tax region) by PCR. It was concluded that the prevalence of MF in Pakistani population is comparable to the Western data, and that EBV association to MF cases was higher than in Western studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12516000     DOI: 10.1007/bf03032394

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  36 in total

1.  Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.

Authors:  M N Wrightham; J P Stewart; N J Janjua; S D Pepper; C Sample; C M Rooney; J R Arrand
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

Review 2.  Mycosis fungoides. Diagnosis and pathogenesis.

Authors:  M Barcos
Journal:  Am J Clin Pathol       Date:  1993-04       Impact factor: 2.493

3.  Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations.

Authors:  I Anagnostopoulos; M Hummel; P Kaudewitz; P Korbjuhn; L Leoncini; H Stein
Journal:  Br J Dermatol       Date:  1996-02       Impact factor: 9.302

4.  The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders.

Authors:  K P McCarthy; J P Sloane; J H Kabarowski; E Matutes; L M Wiedemann
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

5.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.

Authors:  J Sample; L Young; B Martin; T Chatman; E Kieff; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  T-cell receptor variable region genes in cutaneous T-cell lymphomas.

Authors:  P Thor Straten; E Ralfkiaer; J Hendriks; T Seremet; G L Vejlsgaard; J Zeuthen
Journal:  Br J Dermatol       Date:  1998-01       Impact factor: 9.302

7.  Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.

Authors:  B Z Katz; N Raab-Traub; G Miller
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

8.  Immunopathology of cutaneous T-cell lymphomas.

Authors:  K Nasu; J Said; E Vonderheid; J Olerud; D Sako; M Kadin
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

9.  Strain variation in Epstein-Barr virus immediate early genes.

Authors:  G Packham; M Brimmell; D Cook; A J Sinclair; P J Farrell
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

10.  Absence of Epstein-Barr viral encoded RNA (EBER) in primary cutaneous t-cell lymphoma.

Authors:  C A Angel; D N Slater; J A Royds; S N Nelson; S S Bleehen
Journal:  J Pathol       Date:  1996-02       Impact factor: 7.996

View more
  2 in total

1.  Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.

Authors:  Bradley M Haverkos; Alejandro A Gru; Susan M Geyer; Anissa K Bingman; Jessica A Hemminger; Anjali Mishra; Henry K Wong; Preeti Pancholi; Aharon G Freud; Michael A Caligiuri; Robert A Baiocchi; Pierluigi Porcu
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-08

2.  Evaluation of the Association Between Epstein-Barr Virus and Mycosis Fungoides.

Authors:  Yalda Nahidi; Naser Tayyebi Meibodi; Kiarash Ghazvini; Habiballah Esmaily; Mitra Hesamifard
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.